Significantly More Smokers With Mild-To-Moderate COPD Quit Smoking Using CHANTIX/CHAMPIX® (Varenicline) Compared With Placebo

Donald P. Tashkin, M.D., Primary Study Investigator, Emeritus Professor of Medicine at UCLA; If embedding or linking to these sound bites, please do so in their entirety, including Important Safety Information. For Full Prescribing Information and Medication Guide, please go to the following links: http://www.pfizer.com/ files/products/uspi_chantix.pdf and http://www.pfizer.com/files/ products/ppi_chantix.pdf, respectively.